Literature DB >> 16174267

Imbalance between soluble tumour necrosis factor receptors type 1 and 2 in chronic periodontitis.

Ikuyo Ikezawa1, Hideaki Tai, Yasuko Shimada, Yasutaka Komatsu, Johnah C Galicia, Hiromasa Yoshie.   

Abstract

BACKGROUND: Soluble types of tumour necrosis factor (TNF) receptors type 1 and 2 modulate the TNF-alpha-mediated inflammatory responses in chronic periodontitis (CP).
OBJECTIVES: This study investigated the levels of TNF-alpha, soluble TNF receptor type 1 and 2 in gingival crevicular fluid (GCF) and serum of healthy subjects and CP patients.
MATERIALS AND METHODS: Thirty-eight sera and 73 GCF samples were collected from 16 healthy subjects and 22 CP patients. GCF was collected from probing pocket depth (PPD)< or =3 mm sites of healthy subjects, PPD< or =3, 4-6 and > or =7 mm sites of CP patients. The levels of TNF-alpha, soluble TNF receptor type 1 and 2 in the serum and GCF were quantified by enzyme-linked immunosorbant assay.
RESULTS: The total amounts of TNF-alpha, soluble TNF receptor type 1 and 2 in GCF significantly elevated with increasing PPD in both site-based (p<0.05) and subject-based (p<0.05) analyses. However, their levels progressively diverged as the pocket depths increased, with the soluble TNF receptor type 2 level being comparatively lower than type 1. On the other hand, soluble TNF receptor type 2/type 1 ratios in GCF decreased as the severity of periodontitis increased (p<0.0001).
CONCLUSION: The imbalance between soluble TNF receptor type 1 and 2 levels in GCF could be related to CP severity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174267     DOI: 10.1111/j.1600-051X.2005.00832.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  10 in total

1.  Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats.

Authors:  R Di Paola; E Mazzon; C Muià; C Crisafulli; D Terrana; S Greco; D Britti; D Santori; G Oteri; G Cordasco; S Cuzzocrea
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

2.  Cloricromene, a coumarine derivative, reduced the development of periodontitis in rats.

Authors:  Carmelo Muià; Emanuela Mazzon; Daniele Zito; Daniele Maiere; Domenico Britti; Concetta Crisafulli; Giacomo Oteri; Giancarlo Cordasco; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-28       Impact factor: 3.000

3.  Evaluation of IL-23p19/Ebi3 (IL-39) gingival crevicular fluid levels in periodontal health, gingivitis, and periodontitis.

Authors:  Aysegul Sari; Serdar Dogan; Luigi Nibali; Serhat Koseoglu
Journal:  Clin Oral Investig       Date:  2022-08-20       Impact factor: 3.606

4.  Effects of orally administered lactoferrin and lactoperoxidase-containing tablets on clinical and bacteriological profiles in chronic periodontitis patients.

Authors:  Eiju Shimizu; Tetsuo Kobayashi; Hiroyuki Wakabayashi; Koji Yamauchi; Keiji Iwatsuki; Hiromasa Yoshie
Journal:  Int J Dent       Date:  2011-04-03

Review 5.  Host Responses in the Link Between Periodontitis and Rheumatoid Arthritis.

Authors:  Tetsuo Kobayashi; Hiromasa Yoshie
Journal:  Curr Oral Health Rep       Date:  2015

Review 6.  Identification of Gingival Crevicular Fluid Sampling, Analytical Methods, and Oral Biomarkers for the Diagnosis and Monitoring of Periodontal Diseases: A Systematic Review.

Authors:  Zeyad Nazar Majeed; Koshy Philip; A M Alabsi; Saravanan Pushparajan; Dasan Swaminathan
Journal:  Dis Markers       Date:  2016-12-15       Impact factor: 3.434

7.  Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis.

Authors:  Jeneen Panezai; Ambereen Ghaffar; Mohammad Altamash; Per-Erik Engström; Anders Larsson
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

8.  Cytokine Thresholds in Gingival Crevicular Fluid with Potential Diagnosis of Chronic Periodontitis Differentiating by Smoking Status.

Authors:  N Arias-Bujanda; A Regueira-Iglesias; M Alonso-Sampedro; M M González-Peteiro; A Mira; C Balsa-Castro; I Tomás
Journal:  Sci Rep       Date:  2018-12-20       Impact factor: 4.379

9.  Comparative Evaluation of Serum Tumor Necrosis Factor α in Health and Chronic Periodontitis: A Case-Control Study.

Authors:  Prince Jain; Aditi Ved; Rajat Dubey; Neha Singh; Anuj Singh Parihar; Rochira Maytreyee
Journal:  Contemp Clin Dent       Date:  2020-12-20

10.  Estimation of salivary tumor necrosis factor-alpha in chronic and aggressive periodontitis patients.

Authors:  Sheeja S Varghese; Hima Thomas; N D Jayakumar; M Sankari; Reema Lakshmanan
Journal:  Contemp Clin Dent       Date:  2015-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.